• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基质金属蛋白酶-2、9在胆脂瘤和中耳癌中的表达]

[Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].

作者信息

Zhu W, Xie Y, Wang P

机构信息

Department of Otorhinolaryngology, First College of Norman Bethune University of Medical Sciences, Changchun 130021, China.

出版信息

Zhonghua Er Bi Yan Hou Ke Za Zhi. 2001 Apr;36(2):119-22.

PMID:12761978
Abstract

OBJECTIVE

To study various expressions and roles of MMP-2, 9 in cholesteatoma and middle ear cancer.

METHODS

MMP-2 and MMP-9 were detected with immunohistochemical methods using monoclonal antibody in 36 cholesteatomas, 10 CAMS and 16 middle ear cancer.

RESULTS

The stain in cholesteatoma was stronger than that in CAMS and NAMS. Expressions of MMP-2, 9 were seen in all layers of the epithelium in CA and the stain was strongest in basement membrane. The positive rates of stain was 83% and 50% in CA and CAMS respectively. There was weak stain in 2 NAMS. In middle ear cancer, the expression rates of MMP-9 and MMP-2 were 50% (8/16) and 56.25% (9/16) respectively. The expression level was correlated with tumor differentiation and its clinical stage. Expressions of MMP-2 and MMP-9 were closely related in cholesteatoma. There was no relationship between expressions of MMP-2 and MMP-9 in middle ear cancer.

CONCLUSION

Cholesteatoma has a similar feature with middle ear cancer in invading surrounding of surround bone matrix. The disorder between MMPs and its inhibitor was one of reasons for bone absorption of cholesteatoma and middle ear cancer.

摘要

目的

研究基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)在胆脂瘤及中耳癌中的表达情况及作用。

方法

采用单克隆抗体免疫组化法检测36例胆脂瘤、10例慢性化脓性中耳炎(CAMS)及16例中耳癌中MMP-2和MMP-9的表达。

结果

胆脂瘤中的染色强于CAMS和非胆脂瘤性中耳炎(NAMS)。MMP-2、MMP-9在中耳癌上皮各层均有表达,基底膜处染色最强。中耳癌和CAMS的染色阳性率分别为83%和50%。2例NAMS染色较弱。在中耳癌中,MMP-9和MMP-2的表达率分别为50%(8/16)和56.25%(9/16)。表达水平与肿瘤分化程度及临床分期相关。胆脂瘤中MMP-2和MMP-9的表达密切相关。中耳癌中MMP-2和MMP-9的表达无相关性。

结论

胆脂瘤在侵袭周围骨质方面与中耳癌有相似特征。基质金属蛋白酶及其抑制剂之间的失衡是胆脂瘤和中耳癌骨质吸收的原因之一。

相似文献

1
[Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].[基质金属蛋白酶-2、9在胆脂瘤和中耳癌中的表达]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2001 Apr;36(2):119-22.
2
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].基质金属蛋白酶-2和-9在宫颈癌中的表达及其关系研究
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):330-3.
3
Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.基质金属蛋白酶-9在中耳胆脂瘤中的基质表达
Am J Otol. 2000 Sep;21(5):621-4.
4
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.人胆脂瘤中巨噬细胞移动抑制因子(MIF)的检测及其与复发状态、基质金属蛋白酶-3/9、视黄酸受体-β和抗凋亡半乳糖凝集素-3表达相关性的功能意义
Laryngoscope. 2001 Sep;111(9):1656-62. doi: 10.1097/00005537-200109000-00031.
5
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].[基质金属蛋白酶-9、2、7及金属蛋白酶组织抑制剂-1、2、3 mRNA在卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2004 Oct;23(10):1194-8.
6
[Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].[转化生长因子-β1、基质金属蛋白酶-1及其抑制剂在人中耳胆脂瘤中的表达]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Apr;37(2):121-3.
7
[Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].[垂体腺瘤中基质金属蛋白酶及其组织抑制剂的表达与侵袭性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):647-50.
8
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.基质金属蛋白酶(MMP)-2和MMP-9在乳腺癌中的表达:特别提及激活蛋白-2、人表皮生长因子受体2(HER2)及预后
Clin Cancer Res. 2004 Nov 15;10(22):7621-8. doi: 10.1158/1078-0432.CCR-04-1061.
9
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].[SiSo细胞上表达的受体结合癌抗原、血管内皮生长因子及基质金属蛋白酶-9在宫颈癌中的表达及其与癌组织侵袭和转移的相关性]
Zhonghua Yi Xue Za Zhi. 2007 May 22;87(19):1326-9.
10
[Expression and clinical significance of matrix metalloproteinase in gastric stromal tumor].基质金属蛋白酶在胃间质瘤中的表达及临床意义
Zhonghua Wai Ke Za Zhi. 2007 Sep 1;45(17):1196-8.

引用本文的文献

1
Effect of CT manifestations of cholesteatoma on MMP-2, MMP-9 and IL-6 in the serum of patients.胆脂瘤的CT表现对患者血清中基质金属蛋白酶-2、基质金属蛋白酶-9和白细胞介素-6的影响。
Exp Ther Med. 2019 Jun;17(6):4441-4446. doi: 10.3892/etm.2019.7484. Epub 2019 Apr 12.
2
Matrix metalloproteinase 2: an important genetic marker for cholesteatomas.基质金属蛋白酶2:胆脂瘤的重要遗传标志物。
Braz J Otorhinolaryngol. 2007 Jan-Feb;73(1):51-7. doi: 10.1016/s1808-8694(15)31122-8.